Is chronotropic incompetence a limitation in the evaluation of myocardial ischemia and prognosis?

Andrea De Lorenzo1, Gabriel Oliveira, Ana C Ramos

  • 1Diagnostic Imaging Clinic (CDPI), Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Coronary Artery Disease
|November 22, 2013
PubMed

Insights

Chronotropic incompetence (CI) is linked to more severe myocardial ischemia and worse patient outcomes. Myocardial perfusion imaging (MPI) remains valuable for assessing heart health even with CI.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Chronotropic incompetence (CI) is the inability to achieve 85% of maximal predicted heart rate during exercise.
  • Assessing myocardial ischemia and prognosis in patients with CI using myocardial perfusion imaging (MPI) requires further investigation.

Purpose of the Study:

  • To evaluate the impact of chronotropic incompetence (CI) on myocardial ischemia assessment and prognosis in patients undergoing myocardial perfusion single-photon emission computed tomography (MPS).

Main Methods:

  • Exercise/rest MPS was performed on 391 patients, excluding those on negative chronotropic drugs.
  • Summed stress, rest, and difference scores (SSS, SRS, SDS) were calculated.
  • Patients were followed for hard events (death, myocardial infarction) or revascularization.

Main Results:

  • 11.5% of patients had CI, with higher perfusion scores (SSS, SRS, SDS) compared to those without CI.
  • History of myocardial infarction and SDS were independent predictors of CI.
  • Patients with CI experienced higher rates of hard events (12.5% vs 0.9%) and revascularization (20.0% vs 8.1%) than those without CI.

Conclusions:

  • CI is associated with significant myocardial ischemia.
  • Patients with CI exhibit poorer clinical outcomes, including higher rates of hard events and revascularization.
  • MPI retains diagnostic and prognostic value in patients with CI.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
485